This Week in Cell

A systems biology-based analysis of postmortem brain samples from individuals with late-onset Alzheimer's disease suggests a microglial cell and immune function-related network may contribute to the disease. In Cell, researchers from the US, Iceland, and elsewhere looked at gene expression patterns in 1,647 postmortem brain samples from 549 genotyped individuals, including 376 individuals with late-onset Alzheimer's disease and 173 dementia-free control individuals.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.